Why the study?
Does tight blood pressure control reduce cardiovascular and microvascular clinical end points in persons with type 2 diabetes and hypertension?
Does tight blood pressure control reduce cardiovascular and microvascular clinical end points in persons with type 2 diabetes and hypertension?
Tight blood pressure control, particularly targeting a diastolic blood pressure of 80 mm Hg, and the use of ACE inhibitors significantly reduce cardiovascular events and mortality in patients with type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Prioritize ACE inhibitor-based tight BP control in type 2 diabetes; confirms reduced CV events, death, and MI versus calcium-channel blockers.
Snow et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: